Asthma

Benralizumab Safe, Effective for Asthma Patients

August 10, 2020

Article

Results of ANDHI provide additional support on the safety and efficacy of benralizumab for patients with asthma.

Dupilumab Reduces Asthma Exacerbation Rates

August 08, 2020

Article

Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.

GDC-0214 Well-Tolerated for Patients with Mild Asthma

August 08, 2020

Article

In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.

Autopsies, Biopsies Link Lung Injuries to E-Cigarette Use 

August 07, 2020

Article

A new case study  assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .

Tezepelumab Helps Reduce Severe Asthma Exacerbations

August 07, 2020

Article

In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.

Nirsevimab Shows Promise in Preventing RSV Infections in Preterm-Born Infants

August 06, 2020

Article

A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.

Older, Male Asthmatics at Greater COVID-19 Severity Risk

August 05, 2020

Article

New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.

Very Early Spring Onset Associated With Asthma-Related Hospital Admissions

July 07, 2020

Article

There is also an association between late onset of spring and an increase in hospital admissions for asthma.

Developmental Disabilities Linked to Greater Pediatric Asthma Risk

July 02, 2020

Article

ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.

FDA Approves Pre-Filled Dupilumab Pen

June 19, 2020

Article

The FDA is allowing the pen to be used for the treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis (CRSwNP) patients at least 12 years old.

x